Internal Control · 2025
In this section9 topics
- Internal Control — Board Opinion1 item
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies1 item
- Audit Committee & Auditor Observations2 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions2 items
- Counterparties & Transactions3 items
- Policy & Future Trends2 items
Internal Control — Board Opinion
Summary of the Board's Opinion on Internal Control
The Board of Directors reviewed and assessed the adequacy and effectiveness of the Company’s internal-control system based on reports from management, the internal-audit function, and the external auditor, as well as the results of enterprise-wide risk-management monitoring. The Board is of the opinion that the Company’s internal-control system is appropriate and sufficient for current business operations. It supports operational efficiency, ensures the reliability and accuracy of financial reporting, promotes compliance with applicable laws and regulations, and provides a satisfactory level of protection for the Company’s assets.
The Board also places strong emphasis on the continuous enhancement of internal-control processes. Management and relevant functions have been tasked with following up on improvement areas identified through audit recommendations and reporting progress regularly to the Board of Directors and the Audit Committee in order to further strengthen corporate-governance standards and support the Company’s long-term growth.
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| The Committee of Sponsoring Organizations of the Treadway Commission (COSO) | Here is a formal, disclosure-ready English version suitable for the Annual Report / One Report: The IMH Hospital Group places strong emphasis on maintaining an appropriate and effective internal-control system to support efficient and transparent business operations in compliance with applicable laws, regulatory requirements, and good corporate-governance principles, as well as to prevent and mitigate risks that may affect the achievement of the Group’s objectives. In 2025, the IMH Hospital Group continued to develop and monitor its internal-control system across key dimensions, including governance and management structure, risk management, financial and operational controls, information systems, and compliance with laws and internal policies. 1. Governance Structure and AccountabilityThe Board of Directors establishes internal-control policies and oversees the overall framework, while management is responsible for implementation at the operational level. Clear roles and responsibilities are defined to ensure appropriate checks and balances and effective oversight. 2. Risk ManagementThe Company integrates risk-management processes into day-to-day operations by identifying, assessing, and implementing risk-control measures for material risks, including clinical-service risks, information-technology risks, and regulatory-compliance risks. 3. Financial and Operational ControlsThe Company has established appropriate approval processes, segregation of duties, documentation reviews, and budget-monitoring mechanisms to enhance the accuracy and reliability of financial information, as well as operational efficiency. 4. Information Systems and Data SecurityThe Company prioritizes controls over system access, personal-data protection, and business continuity. Measures include access-authorization protocols, data-backup procedures, and contingency plans for information-technology incidents. 5. Monitoring and Continuous ImprovementThe Company monitors the effectiveness of its internal-control system through internal audits, reporting to the Audit Committee, and departmental self-assessments. Assessment results are used to continuously improve operating processes and strengthen overall governance standards. |
Internal Control Deficiencies
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3160
Audit Committee's Opinion on the Head of Internal Audit
The Audit Committee reviewed the qualifications, independence, knowledge, and experience of the Head of Internal Audit, as well as the effectiveness of performance throughout 2025, and concluded that the Head of Internal Audit is suitable for the position and is able to perform duties independently and objectively in accordance with professional internal-audit standards.
The Audit Committee is of the view that the internal-audit function carried out its work in line with the approved annual audit plan, regularly reported audit findings and recommendations to management and the Audit Committee, and continuously followed up on corrective actions and process improvements. These efforts have contributed to strengthening the Company’s internal-control system, risk-management framework, and corporate-governance practices.
Accordingly, the Audit Committee recommended that the Head of Internal Audit continue in the position in order to support the ongoing enhancement of internal controls and corporate governance over the long term.
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
The Company has established systematic and transparent procedures for the appointment, removal, and transfer of the Head of Internal Audit under the oversight of the Audit Committee, in order to ensure that the internal-audit function operates independently, objectively, and effectively in accordance with good corporate-governance principles and professional internal-audit standards.
1. Appointment
The appointment of the Head of Internal Audit must be reviewed by the Audit Committee, taking into consideration qualifications, experience, expertise in internal auditing, risk management, and internal control, as well as independence from operational functions. The Audit Committee’s recommendation is then submitted to the Board of Directors for approval in accordance with the Company’s governance processes.
2. Removal
Any removal of the Head of Internal Audit must be approved by the Audit Committee and proposed to the Board of Directors for final approval, and must be supported by appropriate grounds, such as failure to perform duties in accordance with professional standards, violations of Company policies, or other circumstances stipulated in the Company’s regulations. This is to preserve the independence and credibility of the internal-audit system.
3. Transfer
Any transfer of the Head of Internal Audit to another position within the organization must first be reviewed and approved by the Audit Committee and then submitted to the Board of Directors for approval. This is to prevent any adverse impact on the independence of the internal-audit function and to ensure continuity in internal-control operations.
4. Key Principles Governing the Process
In managing the position of Head of Internal Audit, the Company emphasizes the following principles:
Independence and objectivity in performing duties
Transparency of the review and approval process
Compliance with applicable laws and good-governance practices
Maintenance of continuity in the internal-control system
Related Party Transactions
Has Related Party Transactions
Yes
Related Party Transactions Link
https://www.imhhospital.com/en/investor-relations-en
Counterparties & Transactions
Monetary Unit
1
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Type of Business | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|---|
| Mr. Sittiwat Kamkatwong | Person | Board of Directors | 2025-12-31T00:00 | |
| Miss Poramaporn Pavarojkit | Person | Board of Directors | 2025-12-31T00:00 | |
| University of the Thai Chamber of Commerce | Juristic Person | A private higher education institution operating on a non-profit basis | Mr. Thanavath Phonvichai serves as President of the University of the Thai Chamber of Commerce. He also holds the positions of Chairman of the Board of Directors and Independent Director of the Company. | 2025-12-31T00:00 |
| Excellent Consulting Group Co., Ltd. | Juristic Person | Engaged in consulting services in the areas of commerce and marketing | Mr. Thibdee Mangkalee serves as Managing Director of Excellent Consulting Group Co., Ltd. He also holds the position of Director of the Company. | 2025-12-31T00:00 |
| Nakhon Luang Capital Public Company Limited | Juristic Person | Engaging in the business of depositing and accepting deposits of property, acquiring rights, transferring and accepting transfers of rights or property, leasing, subleasing, and financial leasing. | Mr. Thanavath Phonvichai serves as the Chairman of the Audit Committee, Chairman of the Board of Directors, and Independent Director of the Company. | 2023-12-31T00:00 |
| Primo Trading Co., Ltd. | Juristic Person | Engaging in the Wholesale Distribution of Pharmaceutical and Medical Products | Mr. Thibdee Mangkalee serves as a Director and Executive Director of Primo Trading Co., Ltd. He also serves as a Director of the Company. | 2023-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 7000000.0 · Necessity: The Company has obtained loans from its directors, with interest rates referenced to the 12-month fixed deposit rate (individual) of Bangkok Bank as announced on the date of the agreement. · Description: Loans to Intermedical Care and Lab Hospital Public Company Limited and IMH Silom Hospital Co., Ltd. · As of yesteryear: 3000000.0 · Nature of transaction: Loans Receivable · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that such transactions are reasonable and in the best interest of the Company. · As of year before yesteryear: 0.0 · 28500000.0 · Necessity: The Company has obtained loans from its directors, with interest rates referenced to the 12-month fixed deposit rate (individual) of Bangkok Bank as announced on the date of the agreement. · Description: Loans to IMH Silom Hospital Co., Ltd. · As of yesteryear: 30000000.0 · Nature of transaction: Loans Receivable · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that such transactions are reasonable and in the best interest of the Company. · As of year before yesteryear: 10000000.0 |
| 10000000.0 · Necessity: The Company has obtained loans from its directors, with interest rates referenced to the government bond yield announced by the Ministry of Finance as at the date of the agreement. · Description: Loans to Intermedical Care and Lab Hospital Public Company Limited · As of yesteryear: 10000000.0 · Nature of transaction: Loans Receivable · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that such transactions are reasonable and in the best interest of the Company. · As of year before yesteryear: 0.0 · 0.0 · Necessity: The Company has obtained loans from its directors, with interest rates referenced to the government bond yield announced by the Ministry of Finance as at the date of the agreement. · Description: Loans to IMH Silom Hospital Co., Ltd. · As of yesteryear: 0.0 · Nature of transaction: Loans Receivable · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that such transactions are reasonable and in the best interest of the Company. · As of year before yesteryear: 0.0 |
| 0.0 · Necessity: The Company provides quadrivalent influenza vaccination services, with pricing comparable to that offered to general customers under current market conditions. · Description: Service Revenue – Trade Receivables · As of yesteryear: 0.0 · Nature of transaction: Service Revenue – Trade Receivables · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that such transactions are reasonable and conducted in the ordinary course of business of the Company. · As of year before yesteryear: 0.0 |
| 0.0 · Necessity: The Company has engaged a financial advisor to identify appropriate funding sources, including borrowings and/or private placements, and/or other forms of capital raising. The advisor is responsible for preparing information and relevant documentation, as well as negotiating with investors or funding providers. In addition, the advisor provides strategic guidance on capital raising and assists in structuring suitable financial instruments in compliance with applicable laws and regulations. · Description: Consulting Fees – Trade Payables · As of yesteryear: 0.0 · Nature of transaction: Consulting Fees – Trade Payables · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that such transactions are reasonable and in the best interest of the Company. · As of year before yesteryear: 0.0 |
| 0.0 · Necessity: The Company provides annual health check-up services for employees in accordance with designated health screening programs. The service fees are comparable to the prevailing rates charged to general customers. · Description: Service Revenue – Receivables · As of yesteryear: 0.0 · Nature of transaction: Service Revenue – Receivables · Audit committee opinion: The Audit Committee has reviewed the transaction and is of the opinion that it is reasonable and constitutes a normal business transaction of the Company. · As of year before yesteryear: 0.0 |
| 0.0 · Necessity: The Company provides annual health check-up services for employees in accordance with designated health screening programs. The service fees are comparable to the prevailing rates charged to general customers. · Description: Service Revenue – Receivables · As of yesteryear: 0.0 · Nature of transaction: Service Revenue – Receivables · Audit committee opinion: The Audit Committee has reviewed the transaction and is of the opinion that it is reasonable and constitutes a normal business transaction of the Company. · As of year before yesteryear: 0.0 |
Policy & Future Trends
Policy, Measures & Approval Process
Pursuant to the resolution of the Board of Directors’ Meeting No. 3/2018, held on 14 August 2018 (the first meeting following the Company’s conversion into a public limited company), the Company has established procedures and guidelines for entering into related party transactions as follows:
Transactions between the Company and related parties or persons who may have conflicts of interest must be conducted under normal commercial terms or on an arm’s length basis, comparable to those that a prudent person would undertake with general counterparties under similar circumstances. Such transactions must be carried out with independent bargaining power, free from influence arising from the status of being a director, executive, or related person (as applicable), under reasonable, verifiable conditions, and must not result in any transfer of benefits.
Case 1: Related Party Transactions in the Ordinary Course of Business
For transactions conducted in the ordinary course of business, such as the purchase or sale of goods and services in which the Company operates, the Company may enter into such transactions with related parties provided that the terms are consistent with normal commercial practices and comparable to those with general counterparties under similar circumstances, with independent bargaining power and without undue influence from any related status.
The Company shall prepare a summary of such transactions and report them to the Audit Committee and the Board of Directors at least on a quarterly basis.
Case 2: Other Related Party Transactions
For related party transactions other than those in Case 1, the Company requires the Audit Committee to review and provide opinions on the necessity of entering into the transaction and the appropriateness of the pricing. This includes assessing whether the terms are consistent with normal market practices, comparable to transactions with external parties, and based on fair, reasonable, and verifiable pricing.
In cases where the Audit Committee lacks sufficient expertise to assess such transactions, the Company shall appoint an independent expert or the Company’s auditor to provide an opinion on the transaction. Such opinions shall be used to support the decision-making process of the Board of Directors or shareholders, as applicable.
All related party transactions involving potential conflicts of interest must be reviewed by the Audit Committee and approved by the Board of Directors, with Audit Committee members attending the meeting. Directors with vested interests in such transactions shall abstain from voting.
The Board of Directors is responsible for ensuring that the Company complies with applicable laws relating to securities and exchange, as well as the rules, regulations, notifications, orders, or requirements of the Stock Exchange of Thailand (SET), the Securities and Exchange Commission (SEC), and the Capital Market Supervisory Board. This includes compliance with requirements relating to the disclosure of related party transactions, as well as the acquisition or disposal of significant assets of the Company. In addition, the Company discloses such related party transactions in the notes to the financial statements audited by the Company’s auditor, the Form 56-1 One Report, and other information disclosures in accordance with the requirements of the Stock Exchange of Thailand and relevant regulatory authorities.
Future Trends in Related Party Transactions
In the future, should the Company and its subsidiaries enter into related party transactions with persons who may have conflicts of interest, such transactions shall be conducted in accordance with the Company’s established procedures and approval processes. Directors who have an interest in such transactions shall not participate in the approval process, to ensure that decisions are free from conflicts of interest and are in the best interests of all shareholders.
In this regard, any related party transactions undertaken by the Company or its subsidiaries with persons who may have, or may potentially have, conflicts of interest shall be reviewed by the Audit Committee, which will provide its opinion on the necessity and appropriateness of such transactions. The assessment shall consider whether the terms are consistent with normal commercial practices.
The Board of Directors shall ensure that the Company complies with applicable securities and exchange laws, as well as the rules, regulations, notifications, orders, and requirements of the Stock Exchange of Thailand. This includes compliance with disclosure requirements for related party transactions and the acquisition or disposal of significant assets of the Company or its subsidiaries, as well as adherence to accounting standards prescribed by the Federation of Accounting Professions.
The Company shall disclose such related party transactions in the notes to the financial statements audited by the Company’s auditor. In the event that the Company’s ordinary shares are listed on the Stock Exchange of Thailand, such transactions will also be disclosed in the Annual Registration Statement (Form 56-1 One Report) in accordance with the securities and exchange laws.

